Renal metastases as the initial presentation of papillary thyroid carcinoma: A case report and literature review

por Gao, Yunfei, Deng, Weiye, Chen, Yanfeng, Fan, Yunping, Guo, Zhuming
Publicado 2017

Clinicopathologic characteristics of second primary squamous cell carcinoma in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy

por Wang, Xi, Wang, Shunlan, Cao, Yang, Li, Chunqiao, Fang, Caishan, He, Weiping, Guo, Zhuming
Publicado 2023

Author Correction: Clinicopathologic characteristics of second primary squamous cell carcinoma in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy

por Wang, Xi, Wang, Shunlan, Cao, Yang, Li, Chunqiao, Fang, Caishan, He, Weiping, Guo, Zhuming
Publicado 2023

Upregulation of OIP5-AS1 Predicts Poor Prognosis and Contributes to Thyroid Cancer Cell Proliferation and Migration

por Li, Qiuli, Chen, Weichao, Luo, Rongzhen, Zhang, Zhiyi, Song, Ming, Chen, Wenkuan, Yang, Zhongyuan, Yang, Yuanzhong, Guo, Zhuming, Yang, Ankui
Publicado 2020

Retraction Notice to: Upregulation of OIP5-AS1 Predicts Poor Prognosis and Contributes to Thyroid Cancer Cell Proliferation and Migration

por Li, Qiuli, Chen, Weichao, Luo, Rongzhen, Zhang, Zhiyi, Song, Ming, Chen, Wenkuan, Yang, Zhongyuan, Yang, Yuanzhong, Guo, Zhuming, Yang, Ankui
Publicado 2022

Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma

por Hong, Shubin, Lin, Bo, Xu, Minjie, Zhang, Quan, Huo, Zijun, Su, Mingyang, Ma, Chengcheng, Liang, Jinyu, Yu, Shuang, He, Qiye, Su, Zhixi, Li, Yanbing, Liu, Rui, Guo, Zhuming, Lv, Weiming, Xiao, Haipeng
Publicado 2023

Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial

por Chi, Yihebali, Zheng, Xiangqian, Zhang, Yuan, Shi, Feng, Cheng, Ying, Guo, Zhuming, Ge, Minghua, Qin, Jianwu, Zhang, Jiewu, Li, Zhendong, Zhou, Xiaohong, Huang, Rui, Chen, Xiaohong, Liu, Hui, Cheng, Ruochuan, Xu, Zhengang, Li, Dapeng, Tang, Pingzhang, Gao, Ming
Publicado 2023

Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability

por Hong, Shubin, Xie, Yubin, Cheng, Zhen, Li, Jie, He, Weiman, Guo, Zhuming, Zhang, Quan, Peng, Sui, He, Minghui, Yu, Shuang, Xu, Lixia, Liu, Rengyun, Xu, Tianyi, Zhang, Yunjian, Li, Yanbing, Wang, Jiguang, Lv, Weiming, Yu, Jun, Xiao, Haipeng
Publicado 2022

A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer

por Zheng, Xiangqian, Xu, Zhengang, Ji, Qinghai, Ge, Minghua, Shi, Feng, Qin, Jianwu, Wang, Feng, Chen, Guang, Zhang, Yuan, Huang, Rui, Tan, Jian, Huang, Tao, Li, Sijin, Lv, Zhongwei, Lin, Yansong, Guo, Zhuming, Kubota, Tomoki, Suzuki, Takuya, Ikezawa, Hiroki, Gao, Ming
Publicado 2021

Anlotinib in patients with medullary thyroid carcinoma with negative prognostic factors: A sub-analysis based on the ALTER01031 study

por Zhao, Jingzhu, Chi, Yihebali, Hu, Chuanxiang, Chen, Xiaohong, Ge, Minghua, Zhang, Yuan, Guo, Zhuming, Wang, Jun, Chen, Jie, Zhang, Jiewu, Cheng, Ying, Li, Zhendong, Liu, Hui, Qin, Jianwu, Zhu, Jingqiang, Cheng, Ruochuan, Xu, Zhengang, Li, Dapeng, Tang, Pingzhang, Gao, Ming, Zheng, Xiangqian
Publicado 2022

2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma

por Gao, Ming, Ge, Minghua, Ji, Qinghai, Cheng, Ruochuan, Lu, Hankui, Guan, Haixia, Gao, Li, Guo, Zhuming, Huang, Tao, Huang, Xiaoming, Li, Xiaoming, Lin, Yansong, Liu, Qinjiang, Ni, Xin, Pan, Yi, Qin, Jianwu, Shan, Zhongyan, Sun, Hui, Wang, Xudong, Xu, Zhengang, Yu, Yang, Zhao, Daiwei, Zhang, Naisong, Zhang, Sheng, Zheng, Ying, Zhu, Jingqiang, Li, Dapeng, Zheng, Xiangqian, Chinese Association of Thyroid Oncology, (CATO), Chinese Anti-Cancer Association
Publicado 2017

2017 Chinese expert consensus on the clinical application of serum marker for thyroid cancer

por Gao, Ming, Ge, Minghua, Ji, Qinghai, Cheng, Ruochuan, Lu, Hankui, Guan, Haixia, Cui, Wei, Gao, Li, Gao, Zairong, Guo, Lin, Guo, Zhuming, Huang, Tao, Huang, Xiaoming, Lin, Yansong, Liu, Qinjiang, Ni, Xin, Qin, Jianwu, Ren, Li, Shan, Zhongyan, Sun, Hui, Wang, Xudong, Xu, Zhengang, Yu, Yang, Zhang, Bin, Zhao, Daiwei, Zheng, Ying, Zhu, Jingqiang, Zheng, Xiangqian, Chinese Association of Thyroid Oncology (CATO), China Anti-Cancer Association
Publicado 2018